Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


bioMérieux bulks up with BioFire – but at too high a price?

This article was originally published in Clinica

Executive Summary

French diagnostics company bioMérieux is consolidating its position in the infectious disease testing market with the planned acquisition of BioFire Diagnostics, a privately held US firm specializing in rapid, multiplex diagnostics. However, with bioMérieux paying $450m, as well as taking on BioFire’s net debt, some analysts believe that the Marcy l’Etoile firm's offer may be overly generous.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts